Loading…
Loading…
RDTCF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RDTCF and 80,000+ other tickers.
See exactly how RDTCF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RDTCF and 80,000+ other tickers.
Rapid Dose Therapeutics Corp., a life sciences enterprise based in Burlington, Canada, specializes in cutting-edge drug delivery systems aimed at enhancing health and well-being for individuals across Canada. Their core offering is the QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter remedies—directly into the bloodstream. The product line includes targeted solutions like QuickStrip energy, infused with caffeine; QuickStrip B12, providing vitamin B12; and QuickStrip…
Burlington, Ontario--(Newsfile Corp. - August 20, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"),
Burlington, Ontario--(Newsfile Corp. - July 28, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("Rapid Dose" or "RDT"),
Burlington, Ontario--(Newsfile Corp. - July 7, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian
Burlington, Ontario--(Newsfile Corp. - April 13, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"),
Burlington, Ontario--(Newsfile Corp. - April 6, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on March 31, 2026. The Company expects to issue the Common Shares no later than April 15, 2026.